Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study

Acute exacerbations of COPD (AECOPD) are clinically significant events having therapeutic and prognostic consequences. However, there is a lot of variation in its clinical manifestations described by phenotypes. The phenotypes of AECOPD were categorized in this study based on pathology and exposure....

Full description

Bibliographic Details
Main Authors: Mohammed Kaleem Ullah, Ashwaghosha Parthasarathi, Jayaraj Biligere Siddaiah, Prashant Vishwanath, Swapna Upadhyay, Koustav Ganguly, Padukudru Anand Mahesh
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Toxics
Subjects:
Online Access:https://www.mdpi.com/2305-6304/10/11/667
_version_ 1827645420402114560
author Mohammed Kaleem Ullah
Ashwaghosha Parthasarathi
Jayaraj Biligere Siddaiah
Prashant Vishwanath
Swapna Upadhyay
Koustav Ganguly
Padukudru Anand Mahesh
author_facet Mohammed Kaleem Ullah
Ashwaghosha Parthasarathi
Jayaraj Biligere Siddaiah
Prashant Vishwanath
Swapna Upadhyay
Koustav Ganguly
Padukudru Anand Mahesh
author_sort Mohammed Kaleem Ullah
collection DOAJ
description Acute exacerbations of COPD (AECOPD) are clinically significant events having therapeutic and prognostic consequences. However, there is a lot of variation in its clinical manifestations described by phenotypes. The phenotypes of AECOPD were categorized in this study based on pathology and exposure. In our cross-sectional study, conducted between 1 January 2016 to 31 December 2020, the patients were categorized into six groups based on pathology: non-bacterial and non-eosinophilic; bacterial; eosinophilic; bacterial infection with eosinophilia; pneumonia; and bronchiectasis. Further, four groups were classified based on exposure to tobacco smoke (TS), biomass smoke (BMS), both, or no exposure. Cox proportional-hazards regression analyses were performed to assess hazard ratios, and Kaplan–Meier analysis was performed to assess survival, which was then compared using the log-rank test. The odds ratio (OR) and independent predictors of ward admission type and length of hospital stay were assessed using binomial logistic regression analyses. Of the 2236 subjects, 2194 were selected. The median age of the cohort was 67.0 (60.0 to 74.0) and 75.2% were males. Mortality rates were higher in females than in males (6.2% vs. 2.3%). AECOPD-B (bacterial infection) subjects [HR 95% CI 6.42 (3.06–13.46)], followed by AECOPD-P (pneumonia) subjects [HR (95% CI: 4.33 (2.01–9.30)], were at higher mortality risk and had a more extended hospital stay (6.0 (4.0 to 9.5) days; 6.0 (4.0 to 10.0). Subjects with TS and BMS-AECOPD [HR 95% CI 7.24 (1.53–34.29)], followed by BMS-AECOPD [HR 95% CI 5.28 (2.46–11.35)], had higher mortality risk. Different phenotypes have different impacts on AECOPD clinical outcomes. A better understanding of AECOPD phenotypes could contribute to developing an algorithm for the precise management of different phenotypes.
first_indexed 2024-03-09T18:35:10Z
format Article
id doaj.art-5764341914d141b1b764f238bb921858
institution Directory Open Access Journal
issn 2305-6304
language English
last_indexed 2024-03-09T18:35:10Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Toxics
spelling doaj.art-5764341914d141b1b764f238bb9218582023-11-24T07:09:58ZengMDPI AGToxics2305-63042022-11-01101166710.3390/toxics10110667Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional StudyMohammed Kaleem Ullah0Ashwaghosha Parthasarathi1Jayaraj Biligere Siddaiah2Prashant Vishwanath3Swapna Upadhyay4Koustav Ganguly5Padukudru Anand Mahesh6Centre for Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaAllergy, Asthma, and Chest Centre, Krishnamurthypuram, Mysore 570004, Karnataka, IndiaDepartment of Respiratory Medicine, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaCentre for Excellence in Molecular Biology and Regenerative Medicine, Department of Biochemistry, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaUnit of Integrative Toxicology, Institute of Environmental Medicine (IMM), Karolinska Institutet, 17177 Stockholm, SwedenUnit of Integrative Toxicology, Institute of Environmental Medicine (IMM), Karolinska Institutet, 17177 Stockholm, SwedenDepartment of Respiratory Medicine, JSS Medical College, JSSAHER, Mysore 570015, Karnataka, IndiaAcute exacerbations of COPD (AECOPD) are clinically significant events having therapeutic and prognostic consequences. However, there is a lot of variation in its clinical manifestations described by phenotypes. The phenotypes of AECOPD were categorized in this study based on pathology and exposure. In our cross-sectional study, conducted between 1 January 2016 to 31 December 2020, the patients were categorized into six groups based on pathology: non-bacterial and non-eosinophilic; bacterial; eosinophilic; bacterial infection with eosinophilia; pneumonia; and bronchiectasis. Further, four groups were classified based on exposure to tobacco smoke (TS), biomass smoke (BMS), both, or no exposure. Cox proportional-hazards regression analyses were performed to assess hazard ratios, and Kaplan–Meier analysis was performed to assess survival, which was then compared using the log-rank test. The odds ratio (OR) and independent predictors of ward admission type and length of hospital stay were assessed using binomial logistic regression analyses. Of the 2236 subjects, 2194 were selected. The median age of the cohort was 67.0 (60.0 to 74.0) and 75.2% were males. Mortality rates were higher in females than in males (6.2% vs. 2.3%). AECOPD-B (bacterial infection) subjects [HR 95% CI 6.42 (3.06–13.46)], followed by AECOPD-P (pneumonia) subjects [HR (95% CI: 4.33 (2.01–9.30)], were at higher mortality risk and had a more extended hospital stay (6.0 (4.0 to 9.5) days; 6.0 (4.0 to 10.0). Subjects with TS and BMS-AECOPD [HR 95% CI 7.24 (1.53–34.29)], followed by BMS-AECOPD [HR 95% CI 5.28 (2.46–11.35)], had higher mortality risk. Different phenotypes have different impacts on AECOPD clinical outcomes. A better understanding of AECOPD phenotypes could contribute to developing an algorithm for the precise management of different phenotypes.https://www.mdpi.com/2305-6304/10/11/667COPDacute exacerbationphenotypeAECOPDbiomasstobacco
spellingShingle Mohammed Kaleem Ullah
Ashwaghosha Parthasarathi
Jayaraj Biligere Siddaiah
Prashant Vishwanath
Swapna Upadhyay
Koustav Ganguly
Padukudru Anand Mahesh
Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study
Toxics
COPD
acute exacerbation
phenotype
AECOPD
biomass
tobacco
title Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study
title_full Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study
title_fullStr Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study
title_full_unstemmed Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study
title_short Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study
title_sort impact of acute exacerbation and its phenotypes on the clinical outcomes of chronic obstructive pulmonary disease in hospitalized patients a cross sectional study
topic COPD
acute exacerbation
phenotype
AECOPD
biomass
tobacco
url https://www.mdpi.com/2305-6304/10/11/667
work_keys_str_mv AT mohammedkaleemullah impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy
AT ashwaghoshaparthasarathi impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy
AT jayarajbiligeresiddaiah impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy
AT prashantvishwanath impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy
AT swapnaupadhyay impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy
AT koustavganguly impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy
AT padukudruanandmahesh impactofacuteexacerbationanditsphenotypesontheclinicaloutcomesofchronicobstructivepulmonarydiseaseinhospitalizedpatientsacrosssectionalstudy